Literature DB >> 15963480

The role of Toll-like receptor signalling in the pathogenesis of arthritis.

Fabia Brentano1, Diego Kyburz, Olivier Schorr, Renate Gay, Steffen Gay.   

Abstract

Recent evidence highlighted the role of Toll-like receptors (TLRs) as key recognition structures of the innate immune system. The activation of TLRs initiates the production of inflammatory cytokines, chemokines, tissue destructive enzymes, and type I interferons. In addition, TLR signalling plays an important role in the activation and direction of the adaptive immune system by the upregulation of costimulatory molecules of antigen presenting cells. Considering the important role of TLR signalling as a critical link between innate and adaptive immunity it has been proposed that a dysregulation in TLR signalling might be associated with autoimmunity. In this review, recent studies on TLR signal transduction pathways activated by corresponding ligands are summarized and evidence for a possible role of TLR signalling in the pathogenesis of rheumatoid arthritis is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963480     DOI: 10.1016/j.cellimm.2005.04.018

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  53 in total

1.  TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-α levels.

Authors:  Nathan D Chamberlain; Olga M Vila; Michael V Volin; Suncica Volkov; Richard M Pope; William Swedler; Arthur M Mandelin; Shiva Shahrara
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

2.  Role of interferon regulatory factor 7 in serum-transfer arthritis: regulation of interferon-β production.

Authors:  Susan E Sweeney; Maripat Corr; Trevor B Kimbler
Journal:  Arthritis Rheum       Date:  2011-11-10

3.  HMG-CoA reductase inhibitor simvastatin suppresses Toll-like receptor 2 ligand-induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes from rheumatoid arthritis patients.

Authors:  Haobo Lin; Youjun Xiao; Guoqiang Chen; Di Fu; Yujin Ye; Liuqin Liang; Jinjin Fan; Xiuyan Yang; Lin Sun; Hanshi Xu
Journal:  Rheumatol Int       Date:  2010-05-15       Impact factor: 2.631

Review 4.  Toll gates to periodontal host modulation and vaccine therapy.

Authors:  George Hajishengallis
Journal:  Periodontol 2000       Date:  2009       Impact factor: 7.589

5.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

6.  Synoviocyte innate immune responses: II. Pivotal role of IFN regulatory factor 3.

Authors:  Susan E Sweeney; Trevor B Kimbler; Gary S Firestein
Journal:  J Immunol       Date:  2010-05-17       Impact factor: 5.422

7.  Ligation of TLR7 by rheumatoid arthritis synovial fluid single strand RNA induces transcription of TNFα in monocytes.

Authors:  Nathan D Chamberlain; Seung-jae Kim; Olga M Vila; Michael V Volin; Suncica Volkov; Richard M Pope; Shiva Arami; Arthur M Mandelin; Shiva Shahrara
Journal:  Ann Rheum Dis       Date:  2012-06-23       Impact factor: 19.103

8.  The tumour suppressor gene p53 modulates the severity of antigen-induced arthritis and the systemic immune response.

Authors:  M Leech; J R Xue; A Dacumos; P Hall; L Santos; Y Yang; M Li; A R Kitching; E F Morand
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

9.  A comprehensive molecular interaction map for rheumatoid arthritis.

Authors:  Gang Wu; Lisha Zhu; Jennifer E Dent; Christine Nardini
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

10.  Transcriptome analysis describing new immunity and defense genes in peripheral blood mononuclear cells of rheumatoid arthritis patients.

Authors:  Vitor Hugo Teixeira; Robert Olaso; Marie-Laure Martin-Magniette; Sandra Lasbleiz; Laurent Jacq; Catarina Resende Oliveira; Pascal Hilliquin; Ivo Gut; François Cornelis; Elisabeth Petit-Teixeira
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.